These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7825956)

  • 1. Proceedings of the 5th Conference on Oncological Clinical Pharmacology. Reims, France, 8-10 November 1994.
    Anticancer Res; 1994; 14(6A):2267-396. PubMed ID: 7825956
    [No Abstract]   [Full Text] [Related]  

  • 2. The relevance of pharmacology in clinical oncology practice. Pharmacology is (as yet) no relevant...
    McVie JG
    Ann Oncol; 1993 Jun; 4(6):465. PubMed ID: 8353086
    [No Abstract]   [Full Text] [Related]  

  • 3. The relevance of pharmacology in clinical oncology practice. Pharmacology is relevant.
    Gianni L
    Ann Oncol; 1993 Jun; 4(6):463-5. PubMed ID: 8353085
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacometrics and systems biology in oncology: is there an intersection?
    Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):89-90. PubMed ID: 23260011
    [No Abstract]   [Full Text] [Related]  

  • 5. The relevance of pharmacology in clinical oncology practice. The moderator thinks that...
    Workman P
    Ann Oncol; 1993 Jun; 4(6):466-9. PubMed ID: 8353087
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in cancer chemotherapy. Proceedings of a symposium of the 5th European Conference on Clinical Oncology. September 3, 1989, London.
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):1-74. PubMed ID: 2305268
    [No Abstract]   [Full Text] [Related]  

  • 7. On clinical biochemical pharmacology of 5-fluorouracil and anticancer pyrimidines, Marseille, July 22-23, 1978, USA-France agreement in clinical trial and treatment research (NCI-INSERM).
    Bull Cancer; 1979; 66(1):37-100. PubMed ID: 33733
    [No Abstract]   [Full Text] [Related]  

  • 8. The Role of Clinical Pharmacology in Oncology Dose Selection: Advances and Opportunities in Personalized Medicine.
    Shord SS
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S99-S104. PubMed ID: 28921640
    [No Abstract]   [Full Text] [Related]  

  • 9. An interview with Luca Gianni.
    Gianni L
    Lancet; 2010 Jan; 375(9712):367. PubMed ID: 20113815
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the 5th Kuwait International Pharmacy Conference, February 1-3, 2015.
    Phillips OA; Al-Soraj M
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):1-2. PubMed ID: 26986015
    [No Abstract]   [Full Text] [Related]  

  • 11. Geriatric clinical pharmacologist and medical oncologist: a new partnership?
    Vestal RE; Calabresi P
    Clin Pharmacol Ther; 1997 Oct; 62(4):361-4. PubMed ID: 9357386
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging Strategies in Medical Oncology. Proceedings of a symposium held in conjunction with the European Society for Medical Oncology XVII Congress. Lyon, France.
    Cancer Treat Rev; 1993; 19 Suppl C():1-86. PubMed ID: 8106153
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in cancer chemotherapy. Proceedings of a symposium held in conjunction with the 6th European Conference on Clinical Oncology. Florence, Italy, October 29, 1991.
    Ann Oncol; 1992 Aug; 3 Suppl 3():1-67. PubMed ID: 1356416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Introduction].
    Koch M; Monneret C
    Ann Pharm Fr; 2005 Jan; 63(1):4-6. PubMed ID: 15803093
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy Foundation Symposium XII. Innovative Cancer Chemotherapy for Tomorrow. New York City, November 9-11, 1994. Abstracts.
    Cancer Invest; 1995; 13 Suppl 1():1-59. PubMed ID: 7614145
    [No Abstract]   [Full Text] [Related]  

  • 17. [From biology to innovating treatments for tumors: a long struggle].
    Thiery JP
    Ann Pharm Fr; 2005 Jan; 63(1):7-9. PubMed ID: 15803094
    [No Abstract]   [Full Text] [Related]  

  • 18. Paraplatin (carboplatin). Current status and future prospects. Proceedings of a satellite symposium held at Stockholm, Sweden, 19th June 1985, during the 3rd European Conference on Clinical Oncology.
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-152. PubMed ID: 3910214
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proceedings of the 3rd National Conference of Medical Oncology. Irinotecan: present and future. Napoli, Italy, 5 November 2001].
    Tumori; 2001; 87(6):A29-37. PubMed ID: 11995704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.